Arrowstreet Capital’s Quest Diagnostics DGX Stock Holding History

Arrowstreet Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,468	Closed	-$2.25M	–	1961
2026 Q1	$2.25M	Buy	+11,468	New	+$2.23M	﹤0.01%	1376
2025 Q2	–	Sell	-7,965	Closed	-$1.35M	–	1951
2025 Q1	$1.35M	Buy	+7,965	New	+$1.31M	﹤0.01%	1409
2022 Q2	–	Sell	-31,099	Closed	-$4.26M	–	1269
2022 Q1	$4.26M	Sell	31,099 -20,629	-40%	-$2.88M	0.01%	665
2021 Q4	$8.95M	Sell	51,728 -30,272	-37%	-$4.61M	0.01%	680
2021 Q3	$11.9M	Sell	82,000 -106,845	-57%	-$15.6M	0.01%	688
2021 Q2	$24.9M	Sell	188,845 -214,491	-53%	-$28.1M	0.03%	532
2021 Q1	$51.8M	Buy	403,336 +151,404	+60%	+$18.7M	0.07%	282
2020 Q4	$30M	Buy	+251,932	New	+$30.7M	0.04%	448
2020 Q2	–	Sell	-39,800	Closed	-$3.2M	–	2337
2020 Q1	$3.2M	Buy	+39,800	New	+$4.12M	0.01%	905
2018 Q4	–	Sell	-35,000	Closed	-$3.78M	–	1370
2018 Q3	$3.78M	Buy	+35,000	New	+$3.84M	0.01%	561
2018 Q1	–	Sell	-5,300	Closed	-$522K	–	1164
2017 Q4	$522K	Sell	5,300 -47,500	-90%	-$4.5M	﹤0.01%	1063
2017 Q3	$4.94M	Buy	52,800 +38,100	+259%	+$4.04M	0.01%	505
2017 Q2	$1.63M	Buy	+14,700	New	+$1.55M	﹤0.01%	690
2015 Q3	–	Sell	-16,400	Closed	-$1.19M	–	1383
2015 Q2	$1.19M	Buy	+16,400	New	+$1.21M	0.01%	782
2015 Q1	–	Sell	-42,475	Closed	-$2.85M	–	1042
2014 Q4	$2.85M	Buy	+42,475	New	+$2.68M	0.02%	625

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Arrowstreet Capital's DGX Position: Q2 2026 in Review

Arrowstreet Capital sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 11,468 shares — an estimated $2.25M sold.

Arrowstreet Capital first reported a position in DGX in Q4 2014 and held it in 15 quarters. The position peaked at $51.8M in Q1 2021. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Arrowstreet Capital reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
Arrowstreet Capital sold 11,468 Quest Diagnostics shares in Q2 2026, an estimated $2.25M.
Arrowstreet Capital first reported a position in Quest Diagnostics in Q4 2014 and held it in 15 quarters.
Arrowstreet Capital's Quest Diagnostics position peaked at $51.8M in Q1 2021.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.